Longevity and Anti-Senescence Therapy Market Size, Share & Trends Analysis Report By Therapy (Senolytic Drug Therapy, Gene Therapy, Cell Therapy, Mitochondrial Therapy, Immunotherapy, Others), By Application, By Region, And By Segment Forecasts, 2024-2031

Report Id: 1354 Pages: 185 Last Updated: 20 September 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

The Longevity and Anti-Senescence Therapy Market Size is valued at USD 2,736.43 million in 2023 and is predicted to reach USD 4,121.54 million by the year 2030 at a 6.8 % CAGR during the forecast period for 2024-2030.

longevity

Longevity is an effective approach focuses on the extension of health span by slowing the rate of aging. This approach is considered as the most efficient way to combat various aging-related chronic illnesses and disabling conditions. Aging comprises a rising risk of developing a number of neurodegenerative disorders, cardiovascular disease, diabetes, osteoarthritis, and cancer, which are commonly referred to as age-related diseases (ARDs). In the recent years, the development of new interventions and rejuvenation strategies to increase health span by means of supplements and pharmaceuticals targeting aging-related pathologies are in spotlight of a new branch in geriatric medicine, geroscience.  Longevity and Anti-Senescence Therapy is one of such therapy can be classified into four groups: pharmacological therapies, lifestyle related, molecular (genetic and epigenetic) and cellular.

The growing number of geriatric populations across the globe in recent years is expected to bolster demand for Longevity and Anti-Senescence Therapy Market.  According to World Population Prospects 2019 (United Nations, 2019), Global population aged 65 or over was accounted for 703 Million. Globally, geriatric population is anticipated to double by 2050 to reach 1.5 billion. Increasing number of research and investment activities in the development of longevity and anti-senescence therapies is projected to positively influence the industry’s growth over the forecast period.  Another key aspect including rising adoption of advanced technologies such as gene therapy, stem cell, and senolytics Drug Therapy is anticipated to trigger growth in near future. Escalating prevalence of target diseases, especially Cardiovascular Diseases, Neural Degenerative Diseases, Ophthalmology Disorders, Cancer, among the aging population is expected to assist in the growth of the market for Longevity and Anti-Senescence Therapy over the coming years.

Market Segmentation

The global Longevity and Anti-Senescence Therapy market is categorized on the basis of Therapy, Application and region.  On the basis of Therapy, the market is segmented into Senolytic Drug Therapy, Gene Therapy, Cell Therapy, Mitochondrial Therapy, Immunotherapy, and Others. Based on Application the market is segmented into Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Ophthalmology Disorders, and Cancer. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of forecast period.                                 

Competitive Landscape

Some Major Key Players In The Longevity and Anti-Senescence Therapy Market:

  • Acorda Therapeutics,
  • Agex Therapeutics,
  • Antoxerene,
  • Calico Life Sciences,
  • Celgene,
  • Cleara Biotech,
  • Human Longevity Inc.,
  • Insilico Medicine,
  • Oisin Biotechnology,
  • Powervision Inc.,
  • Prana Biotechnology Ltd.,
  • Proteostasis Therapeutics Inc.,
  • Recursion Pharmaceuticals,
  • Restorbio,
  • Sierra Sciences Llc,
  • Senex Biotechnology,
  • Senolytic Therapeutics,
  • Spotlight Bioscience,
  • A. Sciences,
  • Unity Biotechnology,
  • Alkahest, Inc.,
  • Stealth BioTherapeutics,
  • BIOPHYTIS BSA,
  • SIWA Therapeutics,
  • Rejuveron Life Sciences AG,
  • Rubedo Life Sciences, Inc,
  • Lineage Cell Therapeutics,
  • Juvenescence Life,
  • Longevity Biotech CohBar, Inc. (CWBR),
  • Genome Protection Inc.,
  • Navitor Pharmaceuticals, Inc.,
  • Elevian, Inc.
  • Other Market Players

Longevity and Anti-Senescence Therapy Market Report Scope

Report Attribute Specifications
Market Size Value In 2023 USD 2,736.43 Mn
Revenue Forecast In 2031 USD 4,121.54 Mn
Growth Rate CAGR CAGR of 6.0 % from 2024 to 2030
Quantitative Units Representation of revenue in US$ Million and CAGR from 2024 to 2030
Historic Year 2019 to 2023
Forecast Year 2024-2030
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered Therapy, Applications
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape Acorda Therapeutics, Agex Therapeutics, Antoxerene, Calico Life Sciences, Celgene, Cleara Biotech, Human Longevity Inc., Insilico Medicine, Oisin Biotechnology, Powervision Inc., Prana Biotechnology Ltd., Proteostasis Therapeutics Inc., Recursion Pharmaceuticals, Restorbio, Sierra Sciences Llc, Senex Biotechnology, Senolytic Therapeutics, Spotlight Bioscience, T.A. Sciences, Unity Biotechnology, Alkahest, Inc., Stealth BioTherapeutics, BIOPHYTIS BSA, SIWA Therapeutics, Rejuveron Life Sciences AG, Rubedo Life Sciences, Inc, Lineage Cell Therapeutics, Juvenescence Life, Longevity Biotech CohBar, Inc. (CWBR), Genome Protection Inc., Navitor Pharmaceuticals, Inc., Elevian, Inc., Other Prominent Players.
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Market Segmentation

Global Longevity and Anti-Senescence Therapy Market Based on Therapy

  • Senolytic Drug Therapy
  • Gene Therapy
  • Cell Therapy
  • Mitochondrial Therapy
  • Immunotherapy
  • Others 

LONGEVITY

Global Longevity and Anti-Senescence Therapy Market Based on Application

  • Longevity
  • Senescence Inhibition
  • Cardiovascular Diseases
  • Neural Degenerative Diseases
  • Ophthalmology Disorders
  • Cancer

Global Longevity and Anti-Senescence Therapy Market Based on Region

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
2882
Security Code field cannot be blank!

Frequently Asked Questions

The Longevity and Anti-Senescence Therapy Market Size is valued at USD 2,736.43 million in 2023 and is predicted to reach USD 4,121.54 million by the

The Longevity and Anti-Senescence Therapy Market is expected to grow at a 6.0 % CAGR during the forecast period for 2024-2030.

Acorda Therapeutics, Agex Therapeutics, Antoxerene, Calico Life Sciences, Celgene, Cleara Biotech, Human Longevity Inc., Insilico Medicine, Others
Get Sample Report Enquiry Before Buying